|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Coronary Disease | |||||
| Coronary Artery Disease | |||||
| Coronary Restenosis | |||||
| 2 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Cardiovascular Diseases | |||||
| Coronary Stenosis | |||||
| Heart Diseases | |||||
| Myocardial Ischemia | |||||
| Vascular Diseases | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Everolimus | |||||
| 4 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 5 | Sponsors listed in this trial | ||||
| Abbott Vascular | |||||